LiveSpo’s ESG Strategy: A Necessary Choice and Commitment to Society
LiveSpo, a pioneering biotechnology company, leads in research, development, production, and distribution of clinically-tested, pharmaceutical-grade probiotics for seven body gateways towards an antibiotic-free future. Notably, LiveSpo® is the first Vietnamese probiotic brand to attain FDA approval in the US. To fulfill its mission of “Towards an Antibiotic-Free Future,” the company has continuously expanded its global reach, now present in over 20 countries, including stringent markets like the US, EU, and China.
The “Assessment of Current Status and ESG Strategy Development” activity is part of the Pioneer Enterprises Support Program of the USAID IPSC project, funded by the United States Agency for International Development (USAID) and managed by the Enterprise Development Department, Ministry of Planning and Investment. Through this activity, LiveSpo will comprehensively evaluate opportunities and challenges in integrating sustainability into its business operations, thereby charting an optimal implementation roadmap. This activity encompasses enhancing governance efficiency (Governance), reducing environmental impact (Environment), and creating sustainable community value (Social). It marks a significant milestone in LiveSpo’s journey, underscoring its strong commitment to safeguarding community health and the environment.
Mr. Dang Quoc Hung, Executive Director of LiveSpo, shared: “Our ESG strategy is not only a necessary choice in the current context but also LiveSpo’s commitment to the community, society, and the environment. With the support of professional consultants, LiveSpo aspires not only to meet the stringent requirements of international markets but also to make a positive difference in the biotechnology industry, contributing to global community health and environmental protection. We are also investing in new technologies such as Pre-Activated SPL (Pre-Activated Spore Probiotic Technology), enabling our products to deliver faster results, especially in preventing respiratory and digestive diseases. This positions LiveSpo ahead of the curve, offering superior products that meet the needs of domestic and international customers, thereby addressing the global challenge of antibiotic overuse. Additionally, we focus on optimizing our production processes to reduce costs and enhance quality while minimizing negative environmental impacts.”
Mr. Dang Quoc Hung, Executive Director of LiveSpo, during the tripartite meeting
To date, LiveSpo’s scientific reports and clinical trial results on the benefits of spore probiotics have been recognized by global experts and published in top scientific journals like Nature Scientific Reports. LiveSpo aims to become the leading sustainable biotechnology company in Vietnam by 2030. To achieve this, LiveSpo will focus on developing spore probiotic products utilizing advanced technologies to protect user health and work towards an antibiotic-free future.
ESG Strategy to Help LiveSpo Realize its Mission of an Antibiotic-Free Future
Mr. Vuong Quan Ngoc, Consulting Director at FPT Digital, expressed his confidence: “LiveSpo is a partner with a long-term vision and a strong commitment to sustainability. We believe that with a comprehensive ESG strategy, LiveSpo will continue to make its mark in the biotechnology industry and become one of Vietnam’s leading sustainable enterprises.”
Specifically, during this activity, LiveSpo will assess and gain a clear understanding of its current ESG performance, further refine its strategic orientation and ESG roadmap. This process involves establishing a strategic vision with specific sustainable development goals while developing environmental, social, and governance initiatives relevant to the company’s context. Additionally, LiveSpo will focus on analyzing leverage factors to select the most effective solutions for integration into its sustainability journey, choose reporting standards that align with international practices, and establish a monitoring and evaluation system to assess annual ESG performance.
Representing IPSC, Mr. Tran Hoang Thang commented: “As one of the 35 pioneering enterprises honored, LiveSpo is a leading biotechnology company, established in 2010, renowned for its breakthrough water-form, multi-strain, high-concentration spore probiotic technology developed by Vietnamese researchers. A pioneer in researching and developing healthcare products from spore probiotics, LiveSpo introduced the world’s first Spore Probiotic Research Center in 2022. With a focus on providing safe and effective healthcare solutions for an antibiotic-free future, LiveSpo is now present in over 20 countries and continues to strengthen its position in the international market.”
Mr. Tran Hoang Thang, IPSC Representative, highlights LiveSpo’s potential for sustainable development
Amid the growing trend of environmental protection regulations and antibiotic restrictions in healthcare across international markets, LiveSpo has chosen sustainability as its core strategy. Simultaneously, modern consumers are increasingly concerned about safe and effective health products with reduced environmental impact. By committing to a business strategy aligned with sustainable development goals, LiveSpo will not only build solid trust with its customers but also expand its international market share.
The Pioneer Enterprises Support Program is a strategic focus of the USAID IPSC project, aiming to enhance the competitiveness of Vietnam’s private sector and drive sustainable growth. The program concentrates on supporting enterprises with the potential to lead and bring about positive changes in various economic sectors and industries, becoming exemplary pioneers that inspire national pride and showcase the capabilities of “Made by Vietnam” products in the international market.
The ESG strategic consulting activity is a significant milestone, contributing to the aforementioned goal and reaffirming LiveSpo’s commitment to society and the environment. With a comprehensive ESG strategy, LiveSpo will not only expand internationally but also reinforce its pioneering role in the biotechnology industry, bringing immense benefits to the community and the environment. With FPT Digital’s accompaniment, LiveSpo pledges to continue pursuing its sustainability goals, striving towards comprehensive and responsible development.
LiveSpo Pharma
Hotline: 1800 088 808
Website:Â livespo.vn
